Latest Breaking News On - Stephen neidle - Page 1 : comparemela.com

Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023

Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of louisvilleDan neidleHoward donningerMaria roman escorzaGeoff clarkStephen neidleTariq arshadMichaels poirierRaphaeln jigoQualigen therapeutics incAmerican society of clinical oncologyCompany phaseUniversity college londonSchool of pharmacyExchange commission

Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023

Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of louisvilleRaphaeln jigoGeoff clarkStephen neidleMichaels poirierTariq arshadHoward donningerMaria roman escorzaDan neidleExchange commissionUniversity college londonSchool of pharmacyAmerican society of clinical oncologyQualigen therapeutics incAmerican association of cancer research

Qualigen Therapeutics Presents Scientific Data on QN-302 at AACR Special Conference: Pancreatic Cancer 2023

Qualigen Therapeutics Presents Scientific Data on QN-302 at AACR Special Conference: Pancreatic Cancer 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesTariq arshadDan neidleMaria roman escorzaStephen neidleCompany phaseExchange commissionPancreatic cancer researchAmerican academy of cancer researchQualigen therapeutics incTherapeutics presents scientific dataPancreatic cancerOrphan drug designationAmerican academyCancer researchSpecial conference

Qualigen Therapeutics (QLGN) Partners with TD2 for Phase 1 Clinical Development of QN-302

Qualigen Therapeutics (QLGN) Partners with TD2 for Phase 1 Clinical Development of QN-302
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Tariq arshadStephen neidleStephen gatelySchool of pharmacyQualigen therapeutics incTranslational drug developmentUniversity college londonQualigen therapeuticsOrphan drug designationChief medical officerProfessor stephen neidleAdvisory board

Qualigen Therapeutics Partners with TD2 for Phase 1 Clinical Development of QN-302 for the Treatment of Advanced or Metastatic Solid Tumors

Qualigen Therapeutics Partners with TD2 for Phase 1 Clinical Development of QN-302 for the Treatment of Advanced or Metastatic Solid Tumors
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Stephen gatelyTariq arshadStephen neidleTranslational drug developmentCompany phaseUniversity college londonExchange commissionQualigen therapeutics incSchool of pharmacyQualigen therapeuticsOrphan drug designationChief medical officerProfessor stephen neidleAdvisory boardDrug designationFast track